Abstract: A thrombectomy device (100) comprising an aspiration pump (10), a catheter (20) and a valve (30) is provided. The aspiration pump (10) is for providing an negative pressure continuously or by interval. The catheter (20) having a distal end (23), mid portion (22) and a proximal end (21) and defining a longitudinal axis. The valve (30) connects between the aspiration pump (10) and the proximal end (21) of the catheter (20) or connects to the catheter (20). Wherein, the catheter (20) comprises at least one elastic area (24), which is compressed along the longitudinal axis in response to application of the negative pressure and expanded along the longitudinal axis in response to relieve of the negative pressure.

Abstract: A thrombus removal device (100) comprising a catheter (10), at least one valve (20), and a shaft (30) is provided. The catheter (10) has a proximal end (12) and a distal end (11), and defines a longitudinal axis. The at least one valve (20) is positioned and movable longitudinally inside the catheter (10). The shaft (30) is connected with the proximal end (12) of the catheter (10), and comprises a driving mechanism and a wire (34). Wherein, the wire (34) is connected to the driving mechanism at one end and connected to the at least one valve (20) at an opposite end. The driving mechanism is configured to create a sudden movement of the at least one valve (20) toward the proximal end (12) of the catheter (10). By using the thrombus removal device (100), thrombus can be removed from the body of a subject more efficiently.

Abstract: The present invention provides a power bank comprising a battery protection board, controller board, and a host connector. The host connector is compatible with an accessory connector on a fast charger board, and the host connector is connected to the accessory connector for boosting the charging rate of the power bank. The fast charger board connected to the power bank may, for powering laptops and electric bicycles, elevate the output voltage of the power bank to 12V or above. The power bank may further connect with other external components, such as an LED module and a wireless transceiver module, in order to extend the functionality of the power bank.

Abstract: The present invention relates to a portable power bank comprising a battery pack, a first control module and a second control module, wherein the battery pack further comprises at least two cells connected in series, and wherein the first control module and the second control module both electrically connected to a first terminal and a second terminal of the battery pack; the first controller is configured for regulating the DC input voltage for charging the battery pack and the second controller is configured for regulating the DC output voltage for charging an external device.

Abstract: One embodiment provides a method for enzymatic treatment, including the steps of forming a closed space on a local tissue area with a device and infusing an enzyme solution into the closed space for enzymatic treatment. The method according to the embodiment is capable of treating the local tissue area with enzymes for enhancing cell proliferation in the treated tissue area and preventing damage of the adjacent normal tissues. A device and kit used for the method are also provided.

Abstract: A power socket is to be electrically connected to an internal terminal of an electronic device and to be electrically and separably connected to a plug. The plug has a tubular interior surface and an exterior surface. The power socket includes a body, a central terminal, a first conductor, and a second conductor. The body includes a surrounding wall that has an inner surface defining an accommodating space. The central terminal is disposed in the accommodating space, and is electrically connected to the internal terminal. The first conductor is disposed on the inner surface and has a first elastic portion. The second conductor is electrically connected to the central terminal, and has a second elastic portion.

Abstract: A magnetic nanoparticle is provided in the disclosure. The magnetic nanoparticle includes a magnetic nanoparticle; a biocompatible polymer of the following formula (II) covalently coupled to the magnetic nanoparticle, wherein R1 is alkyl, aryl, carboxyl, or amino; n is an integer from 5 to 1000; and m is an integer from 1 to 10.

Abstract: One embodiment provides a method for enzymatic treatment, including the steps of forming a closed space on a local tissue area with a device and infusing an enzyme solution into the closed space for enzymatic treatment. The method according to the embodiment is capable of treating the local tissue area with enzymes for enhancing cell proliferation in the treated tissue area and preventing damage of the adjacent normal tissues. A device and kit used for the method are also provided.

Abstract: One embodiment provides a method for enzymatic treatment, including the steps of forming a closed space on a local tissue area with a device and infusing an enzyme solution into the closed space for enzymatic treatment. The method according to the embodiment is capable of treating the local tissue area with enzymes for enhancing cell proliferation in the treated tissue area and preventing damage of the adjacent normal tissues. A device and kit used for the method are also provided.

Abstract: A thermosensitive nanostructure for hyperthermia treatment. Magnetic nanoparticles are encapsulated in a thermosensitive polymer nanostructure having a lower critical solution temperature (LCST) of about 40-45° C. The thermosensitive polymer nanostructure may carry a drug. When the magnetic nanoparticles are heated to 40-45° C. by application of an alternating magnetic field in hyperthermia treatment, the thermosensitive polymer nanostructure collapses to release the drug, thus providing concurrent drug treatment.

Abstract: One embodiment provides a method for enzymatic treatment, including the steps of forming a closed space on a local tissue area with a device and infusing an enzyme solution into the closed space for enzymatic treatment. The method according to the embodiment is capable of treating the local tissue area with enzymes for enhancing cell proliferation in the treated tissue area and preventing damage of the adjacent normal tissues. A device and kit used for the method are also provided.

Abstract: An implant module for dragging a bone fragment toward a bone is provided. The bone fragment has a first through hole, and the bone has a second through hole. The implant module includes a screw and a stud. The screw has a first section fixed to the bone fragment and a second section provided with a first external thread on its outer surface. The stud is provided with a second external thread on its outer surface for being screwed into the second through hole of the bone. An end of the stud has a screw hole for being screwed with the second section of the screw via the first external thread. A method of repairing avulsion fracture by using the implant module is further provided.

Abstract: A magnetic nanoparticle is provided in the disclosure. The magnetic nanoparticle includes a magnetic nanoparticle; a biocompatible polymer of the following formula (II) covalently coupled to the magnetic nanoparticle, wherein R1 is alkyl, aryl, carboxyl, or amino; n is an integer from 5 to 1000; and m is an integer from 1 to 10.

Abstract: The invention discloses a biocompatible polymer for covalently modifying magnetic nanoparticles. The biocompatible polymer may be coupled to a targeting agent and/or a fluorescent dye. The invention also discloses a magnetic nanoparticle with biocompatibilities comprising the biocompatible polymer.

Abstract: A core-shell structure with magnetic, thermal, and optical characteristics. The optical absorption band is tailorable by choice of the mixing ratio of the core/shell component to give the desired shell thickness. The core-shell structure is particularly suitable for biomedical applications such as MRI (magnetic resonance imaging) developer, specific tissue identification developer, and magnetic thermal therapy.

Abstract: A pharmaceutical microsphere comprises a bioactive agent and a biological carrier that encapsulates the bioactive agent, wherein the biological carrier is crosslinked with a crosslinking agent.

Abstract: A thermosensitive nanostructure for hyperthermia treatment. Magnetic nanoparticles are encapsulated in a thermosensitive polymer nanostructure having a lower critical solution temperature (LCST) of about 40-45° C. The thermosensitive polymer nanostructure may carry a drug. When the magnetic nanoparticles are heated to 40-45° C. by application of an alternating magnetic field in hyperthermia treatment, the thermosensitive polymer nanostructure collapses to release the drug, thus providing concurrent drug treatment.

Abstract: A core-shell structure with magnetic, thermal, and optical characteristics. The optical absorption band is tailorable by choice of the mixing ratio of the core/shell component to give the desired shell thickness. The core-shell structure is particularly suitable for biomedical applications such as MRI (magnetic resonance imaging) developer, specific tissue identification developer, and magnetic thermal therapy.

Abstract: A method of updating firmware of a circuit module includes providing a switch for selectively connecting the circuit module to a computing system and an update module. The circuit module enters a reset mode and an input/output pin of the circuit module switches to an input mode in response to power being supplied to the circuit module. The input/output pin is pulled to a first digital logic value, which controls the switch to connect the circuit module to the update module. While the circuit module is in the reset mode, the circuit module receives updated firmware from the update module. Then the circuit module enters a normal operation mode and switches the input/output pin to an output mode for outputting a second digital logic value. When the input/output pin outputs the second digital logic value, the input/output pin controls the switch to connect the circuit module to the computing system.

Abstract: An amphiphilic block copolymer and a pharmaceutical formulation comprising the same. The amphiphilic block copolymer comprises a poly(lactide) as a hydrophobic block and a poly(oxazoline) as a hydrophilic block.